Dow Chemical collaborates with Bend Research to develop drug-solubility solutions
MIDLAND, Mich. and BEND, Ore. — Dow Chemical and drug-formulation development and manufacturing company Bend Research Inc. are collaborating to provide science-based spray-dried dispersion (SDD) solutions and select enabling new polymers for poorly soluble oral drugs, the companies announced last week.
Dow and Bend Research will work together to provide the industry with fully characterized polymers supported by complete Quality-by-Design (QbD) principles and the ability to tailor materials to meet the performance needs of specific drugs. In addition, the two companies will develop and commercialize new materials for SDDs that address technology gaps in manufacturability and delivery, providing greater drug-product utility and therapeutic performance.
“We welcome the opportunity to further focus Dow’s proven excipient and materials science expertise in the area of enhancing drug solubility, and we are enthusiastic about working with the world leader in spray-dried dispersions to ensure that our customers receive the best possible polymer solutions,” said Bob Maughon, senior R&D director for Dow.